Developer of healthcare tools designed to amplify health diagnostics. The company combines thermal image technology and computer vision to create a standardized and objective assessment for diabetic foot ulcers enhance efficiency in foot assessments, and ensure care, helping patients improve outcomes through precise early detection.
Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.
Castelion is bringing a new approach to defense development and production: one that focuses on short, iterative design cycles, rapid testing in development, and modern commercial manufacturing strategies for production at scale. We’re designing, building, and testing next generation long range strike weapons systems to give America and its Allies a definitive edge and deter future conflicts.
Founded in 2017, Centrifuge creates better technology for financial products. Centrifuge provides asset managers a way to tokenize, manage and distribute their funds onchain and investors better access to a diversified portfolio of high-quality tokenized assets.